Venture round

SEMCAP Health Continues Strategic Investment in SafeRide Health and Secures Memorial Hermann Health System Co-Investment

Retrieved on: 
Thursday, November 2, 2023

PHILADELPHIA, Nov. 02, 2023 (GLOBE NEWSWIRE) -- SEMCAP Health announces its continued support of portfolio company, SafeRide Health , with participation in the company’s recently announced Series C funding.

Key Points: 
  • PHILADELPHIA, Nov. 02, 2023 (GLOBE NEWSWIRE) -- SEMCAP Health announces its continued support of portfolio company, SafeRide Health , with participation in the company’s recently announced Series C funding.
  • This follows SEMCAP Health’s November 2021 initial investment in SafeRide Health, the leading network optimization platform for Non-Emergency Medical Transportation (NEMT).
  • SafeRide Health’s ability to improve member experience and reduce costs for Medicaid and Medicare Advantage beneficiaries also attracted a strategic investment from Memorial Hermann Health System in this latest round.
  • “We invited Memorial Hermann to co-invest alongside us as we recognize the strategic value of SafeRide Health’s technology for health systems and payors who wish to seamlessly integrate transportation into the patient journey while improving efficiency,” said Vic Kats, managing partner of SEMCAP Health.

Sotherly Hotels Inc. Announces Quarterly Preferred Dividends

Retrieved on: 
Tuesday, October 31, 2023

WILLIAMSBURG, Va., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that its Board of Directors has authorized payment of quarterly cash dividends for the Company’s Series B, Series C, and Series D Preferred Stock.

Key Points: 
  • WILLIAMSBURG, Va., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that its Board of Directors has authorized payment of quarterly cash dividends for the Company’s Series B, Series C, and Series D Preferred Stock.
  • The Board of Directors authorized, and the Company has declared, a quarterly cash dividend of $0.50 per share of beneficial interest of the Company’s 8.0% Series B Cumulative Redeemable Perpetual Preferred Stock.
  • The Series B preferred dividend will be paid on December 15, 2023 to shareholders of record as of November 30, 2023.
  • The Series C preferred dividend will be paid on December 15, 2023 to shareholders of record as of November 30, 2023.

AgentSync Raises $50M in Funding to Drive Operational Efficiencies For Insurers and Distributors

Retrieved on: 
Thursday, October 26, 2023

DENVER, Oct. 26, 2023 /PRNewswire/ -- AgentSync, the leader in modern insurance infrastructure, today announced an additional $50 million fundraise, bringing the company's total funding to date to $161 million. The round was co-led by existing investors Craft Ventures and Valor Ventures. Since raising the Series B in Q4 2022, AgentSync has seen 3x ARR growth and more than 2x customer growth. AgentSync works with more than 200 insurance companies spanning carriers, MGAs, and agencies, covering all lines of insurance.

Key Points: 
  • Since raising the Series B in Q4 2022, AgentSync has seen 3x ARR growth and more than 2x customer growth.
  • AgentSync works with more than 200 insurance companies spanning carriers, MGAs, and agencies, covering all lines of insurance.
  • This round of capital allows AgentSync to double down delivering best-in-class products for the nation's largest and most respected carriers.
  • By establishing flexible, scalable connections between insurance distributors and underwriters, AgentSync powers and streamlines the delivery of insurance products.

Presidio Property Trust Announces Series D Preferred Stock Cash Dividend

Retrieved on: 
Thursday, October 26, 2023

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: SQFT; SQFTP; SQFTW) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust (“REIT”), today announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock (the “Series D Preferred Stock”) for the months of October 2023, November 2023 and December 2023.

Key Points: 
  • SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: SQFT; SQFTP; SQFTW) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust (“REIT”), today announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock (the “Series D Preferred Stock”) for the months of October 2023, November 2023 and December 2023.
  • In accordance with the terms of the Series D Preferred Stock, the October 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on November 15, 2023, to shareholders of record of Series D Preferred Stock as of the dividend record date of October 31, 2023.
  • The November 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on December 15, 2023, to shareholders of record of Series D Preferred Stock as of the dividend record date of November 30, 2023.
  • The December 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on January 15, 2024, to shareholders of record of Series D Preferred Stock as of the dividend record date of December 31, 2023.

DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

Retrieved on: 
Tuesday, October 24, 2023

DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today announced a $35.2 million Series B financing, including a $27.1 million Series B first close and $8.1 million in converting outstanding notes.

Key Points: 
  • DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today announced a $35.2 million Series B financing, including a $27.1 million Series B first close and $8.1 million in converting outstanding notes.
  • The Series B was led by new institutional investor, Double Point Ventures, and includes continued support from Viking Global Investors, Civilization Ventures, Olive Tree Capital, and others.
  • These products prioritize the patient experience by addressing the root cause of both diseases with excellent efficacy, safety, and tolerability.
  • Phase 2b open label clinical trial in 10 subjects with DPN (Dermatosis Papulosa Nigra) treated with SM-020 gel 1% twice daily for 28 days.

BitNile Metaverse Regains Compliance with the Nasdaq Voting Rights Rule

Retrieved on: 
Tuesday, October 17, 2023

BitNile Metaverse, Inc. (Nasdaq: BNMV) (“BitNile Metaverse” or the “Company”), announced today that it has regained compliance with the Nasdaq Voting Rights Rule.

Key Points: 
  • BitNile Metaverse, Inc. (Nasdaq: BNMV) (“BitNile Metaverse” or the “Company”), announced today that it has regained compliance with the Nasdaq Voting Rights Rule.
  • On June 21, 2023, the Nasdaq Stock Market (“Nasdaq”) notified the Company that the issuance of the Series B and Series C Preferred Stock violated Nasdaq’s voting rights rule under listing Rule 5640 (the “Voting Rights Rule”).
  • As a result, the Company has regained compliance with the Voting Rights Rule.
  • “We are pleased to regain compliance with Nasdaq’s Voting Rights Rule and look forward to a continued healthy relationship with the exchange.

Edison International Commences Tender Offers to Purchase Its 5.00% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series B and 5.375% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series A For a Maximum Aggregate Purchase Price…

Retrieved on: 
Wednesday, October 11, 2023

The Series B Offer has been assigned an Acceptance Priority Level of 1 and the Series A Offer an Acceptance Priority Level of 2.

Key Points: 
  • The Series B Offer has been assigned an Acceptance Priority Level of 1 and the Series A Offer an Acceptance Priority Level of 2.
  • Accordingly, all Securities validly tendered in the Series B Offer will be accepted for purchase before any validly tendered Securities of the Series A Offer are accepted.
  • In that event, the Series A Preferred Stock that will be accepted for purchase will be subject to proration, as described in the Offer to Purchase.
  • THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE SECURITIES.

Embedded Flash Memory Developer Floadia Raises 1.05 Billion Yen from Inabata and Others

Retrieved on: 
Wednesday, October 11, 2023

TOKYO, Oct. 11, 2023 /PRNewswire/ -- Floadia Corporation (hereinafter referred to as "Floadia"), which develops embedded flash memory IP cores based in the Tokyo suburb of Kodaira-shi, has raised approximately 1.05 billion yen in Series D round.

Key Points: 
  • TOKYO, Oct. 11, 2023 /PRNewswire/ -- Floadia Corporation (hereinafter referred to as "Floadia"), which develops embedded flash memory IP cores based in the Tokyo suburb of Kodaira-shi, has raised approximately 1.05 billion yen in Series D round.
  • Floadia will use the funds raised to strengthen sales activities promoting its current primary business, embedded flash memory IP cores, to semiconductor manufacturers, and to enhance developing ultra-low power consumption AI accelerator chips that utilize flash memory devices.
  • Floadia is developing Computing in Memory (CIM) chips, which use flash memory devices as information transmission media, as a pillar of the next business following flash memory IP cores.
  • Floadia's flash memory solves these issues with analog memory technology and enables advanced AI inference calculations in edge environments with significantly low power consumption.

Leading Remote Health Care Company Optimize Health Completes $18 Million Series B Financing

Retrieved on: 
Tuesday, October 10, 2023

SEATTLE, Oct. 10, 2023 /PRNewswire/ -- Optimize Health, one of the most trusted remote healthcare platforms in the U.S., today announced the completion of its latest financing, raising more than $18 million.

Key Points: 
  • SEATTLE, Oct. 10, 2023 /PRNewswire/ -- Optimize Health, one of the most trusted remote healthcare platforms in the U.S., today announced the completion of its latest financing, raising more than $18 million.
  • The Series B round was led by Foundry and Escalate Capital Partners, with participation from Bonfire Ventures, Daher Capital, Navigate Ventures, Attento Capital, OpenView, 500 Global, SOSV, and Jumpstart Capital.
  • Seattle-based Optimize Health is revolutionizing the healthcare industry through its innovative technology and services to support remote care.
  • The company leverages a leading remote patient monitoring and chronic care management software platform to improve patient outcomes, enhance clinical decision-making, and optimize operational efficiency for healthcare providers.

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

Retrieved on: 
Wednesday, October 4, 2023

MONACO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared:

Key Points: 
  • MONACO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared:
    a cash dividend of $0.50 per share on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares (the “Series C Preferred Shares”) (NYSE: SB.PR.C) for the period from July 30, 2023 to October 29, 2023;
    a cash dividend of $0.50 per share on its 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares (the “Series D Preferred Shares”) (NYSE: SB.PR.D) for the period from July 30, 2023 to October 29, 2023.
  • Each dividend will be paid on October 30, 2023 to all shareholders of record as of October 18, 2023 of the Series C Preferred Shares and of the Series D Preferred Shares, respectively.
  • Dividends on the Series C and D Preferred Shares are payable quarterly in arrears on the 30th day (unless the 30th falls on a weekend or public holiday, in which case the payment date is moved to the next business day) of January, April, July and October of each year.
  • The declaration and payment of dividends, if any, will always be subject to the discretion of the Board of Directors of the Company, and will depend on, among other things, the Company’s earnings, financial condition and cash requirements and availability, the Company’s ability to obtain debt and equity financing on acceptable terms as contemplated by the Company’s growth and leverage strategies, the restrictive covenants in the Company’s existing and future debt instruments and global economic conditions.